Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May;113(5):293-296.
doi: 10.1016/j.acvd.2020.04.003. Epub 2020 Apr 24.

Use of drugs with potential cardiac effect in the setting of SARS-CoV-2 infection

Frederic Sacher  1 , Laurent Fauchier  2 , Serge Boveda  3 , Christian de Chillou  4 , Pascal Defaye  5 , Jean Claude Deharo  6 , Estelle Gandjbakhch  7 , Vincent Probst  8 , Ariel Cohen  9 , Christophe Leclercq  10 ; Working Group of Pacing, Electrophysiology of the French Society of Cardiology, the Board of the French Society of Cardiology
Affiliations

Use of drugs with potential cardiac effect in the setting of SARS-CoV-2 infection

Frederic Sacher et al. Arch Cardiovasc Dis. 2020 May.
No abstract available

Keywords: COVID-19; Covid-19; ECG; Hydroxychloroquine; Long QT; QT long médicamenteux; QT prolonging drugs; SARS-CoV-2; Torsades de pointe.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Cardiac algorithm when prescribing drug that may prolong QT interval in patients with COVID-19 (top panel for outpatients, lower panel for in-hospital patients). bpm: beats per min; ECG: electrocardiogram; eGFR: estimated glomerular filtration rate; K+: potassium; PVC: premature ventricular contractions.
See this image and copyright information in PMC

References

    1. Wang D., Hu B., Hu C., et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 doi: 10.1001/jama.2020.1585. - DOI - PMC - PubMed
    1. Hu H., Ma F., Wei X., Fang Y. Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin. Eur Heart J. 2020 doi: 10.1093/eurheartj/ehaa190. - DOI - PMC - PubMed
    1. Inciardi R.M., Lupi L., Zaccone G., et al. Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19) JAMA Cardiol. 2020 doi: 10.1001/jamacardio.2020.1096. - DOI - PMC - PubMed
    1. Zhou F., Yu T., Du R., et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–1062. - PMC - PubMed
    1. Gautret P., Lagier J.C., Parola P., et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020 [105949] - PMC - PubMed

MeSH terms